Hayat Pharmaceutical Industries Co. PLC

HPIC

JO4121011012

Pharmaceuticals

End-of-day quote Amman S.E. Other stock markets 03:30:00 19/05/2024 am IST			5-day change	1st Jan Change
2.51 ^JOD	0.00%		+1.62%	+4.58%

29/04	Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
31/03	Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hayat Pharmaceutical Industries Appoints Zia Mahmoud Mousa as Chief Financial Officer

May 30, 2017 at 04:00 pm IST

Hayat Pharmaceutical Industries has appointed Zia Mahmoud Mousa as chief financial officer of the company.

Latest news about Hayat Pharmaceutical Industries Co. PLC

Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Full Year Ended December 31, 2023	31/03	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	26/23/26	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the First Quarter Ended March 31, 2023	30/23/30	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Full Year Ended December 31, 2022	12/23/12	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Hayat Pharmaceutical Industries Co. PLC Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	31/21/31	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the Second Quarter Ended June 30, 2021	05/21/05	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the Third Quarter Ended September 30, 2020	27/20/27	CI
Hayat Pharmaceutical Industries Co. plc Announces Earnings Results for the Second Quarter Ended June 30, 2020	27/20/27	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the First Quarter Ended March 31, 2020	07/20/07	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the Second Quarter Ended June 30, 2019	30/19/30	CI
Hayat Pharmaceutical Industries Co. plc Reports Earnings Results for the First Quarter Ended March 31, 2019	30/19/30	CI
Hayat Pharmaceutical Industries Co. Reports Earnings Results for the Full Year Ended December 31, 2018	28/19/28	CI
Hayat Pharmaceutical Industries Appoints Zia Mahmoud Mousa as Chief Financial Officer	30/17/30	CI

Chart Hayat Pharmaceutical Industries Co. PLC

Duration

Period

Chart Hayat Pharmaceutical Industries Co. PLC

More charts

Hayat Pharmaceutical Industries Company PSC is a Jordan-based company engaged in the pharmaceutical sector. The Company specializes in the manufacture of different forms of human pharmaceuticals, veterinary medicines, medical plasters, medical gauze and medical braces, in addition to the production of skin care and beauty supplies and surgical suture. The Companyâs manufacturing facility is spread over an approximately 8,000 square meter area on the outskirts of the capital city Amman. The Companyâs production areas are divided into the following: Solid production area, which covers tablets, capsules, dry suspension, suppositories, syrups and solutions, cream and ointments, and Semi-solid and Liquid production area, which includes creams, ointments, gels and emulsions, suppositories line, syrups line and shampoo line. The Companyâs products include Anti-microbials, Gynecological, Dermatological, Gastrointestinal, Antihypertensives and Vasoactive, Neurological, and Respiratory products.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HAYAT PHARMACEUTICAL INDUSTRIES CO. PLC	+4.58%	3.36Cr
ELI LILLY AND COMPANY	+32.09%	69TCr
NOVO NORDISK A/S	+29.39%	58TCr
JOHNSON & JOHNSON	-1.34%	37TCr
MERCK & CO., INC.	+20.34%	33TCr
ABBVIE INC.	+7.39%	29TCr
ASTRAZENECA PLC	+13.79%	24TCr
ROCHE HOLDING AG	-3.03%	21TCr
NOVARTIS AG	+10.02%	21TCr
AMGEN INC.	+8.49%	17TCr

Other Pharmaceuticals

Hayat Pharmaceutical Industries Co. PLC

Equities

HPIC

JO4121011012

Pharmaceuticals

Hayat Pharmaceutical Industries Appoints Zia Mahmoud Mousa as Chief Financial Officer

Latest news about Hayat Pharmaceutical Industries Co. PLC

Chart Hayat Pharmaceutical Industries Co. PLC

Company Profile

Income Statement Evolution

Sector Other Pharmaceuticals